Oligosymptomatic adrenomyeloneuropathy due to a novel mutation in the ABCD1 start codon

Dunkl, Veronika; Rau, Isabella; Wunderlich, Gilbert; Fink, Gereon R.; Lehmann, Helmar C.

doi:10.1016/j.jns.2016.05.047

Search citation statements

Order By: Relevance

Paper Sections

Select...

Literature Review Of Patients With Amn Reported In China1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We reviewed 18 papers including 32 cases with AMN: the clinical features of these patients were summarized in Table 1 . 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 …”

Section: Literature Review Of Patients With Amn Reported In Chinamentioning

confidence: 99%

A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review

Zhang

Chen

et al. 2021

Genes & Diseases

View full text Add to dashboard Cite

Adrenomyeloneuropathy (AMN) is a kind of varied disease caused by ABCD1 gene mutation and characterized by very-long-chain fatty acids (VLCFA) accumulation. It is diagnosed by clinical features, high VLCFAs levels and ABCD1 gene mutation. AMN is rarely reported in Chinese population. In this study, we report the genetic and clinical features of a Chinese pure AMN patient. Meanwhile, we conducted a literature review of AMN cases to summarize the characteristics of AMN. We report a rare Chinese pure AMN case with slowly progressive weakness of the lower extremities, caused by a novel c.1202G > A mutation in ABCD1 gene. The literature review indicates that spastic paraplegia is the mainly clinical manifestation in patients with AMN. VLCFAs and ABCD1 gene test should be performed in patients with spastic paraplegia of the lower limbs to diagnose AMN.

show abstract